Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease.
第一作者:
Chunyan,Niu
第一单位:
Department of Gastroenterology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. nchy69@163.com.
作者:
医学主题词
纳米粒子(Nanoparticles);动物(Animals);半乳糖(Galactose);小鼠(Mice);炎症(Inflammation);脂类(Lipids);砜类(Sulfones);人类(Humans);男(雄)性(Male);脂肪肝(Fatty Liver);小鼠, 近交C57BL(Mice, Inbred C57BL);磺胺类(Sulfonamides);呋喃类(Furans);肝(Liver);粒子大小(Particle Size);茚类(Indenes)
DOI
10.1039/d5tb02289d
PMID
41848629
发布时间
2026-04-01
- 浏览0
Journal of materials chemistry. B
2026年14卷13期
4173-4182页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



